130 related articles for article (PubMed ID: 33608980)
1. STAT1 is a key gene in a gene regulatory network related to immune phenotypes in bladder cancer: An integrative analysis of multi-omics data.
Weng H; Yuan S; Huang Q; Zeng XT; Wang XH
J Cell Mol Med; 2021 Apr; 25(7):3258-3271. PubMed ID: 33608980
[TBL] [Abstract][Full Text] [Related]
2. Unraveling metabolic characteristics and clinical implications in gastric cancer through single-cell resolution analysis.
Wang W; Li C; Dai Y; Wu Q; Yu W
Front Mol Biosci; 2024; 11():1399679. PubMed ID: 38831933
[No Abstract] [Full Text] [Related]
3. Identification of novel genera and subcluster classifications for mycobacteriophages.
O'Connell LM; Buttimer C; Bottacini F; Coffey A; O'Mahony JM
Microbiome Res Rep; 2023; 2(3):21. PubMed ID: 38046825
[No Abstract] [Full Text] [Related]
4. Molecular and Clinicopathological Characterization of a Prognostic Immune Gene Signature Associated With MGMT Methylation in Glioblastoma.
Zhao L; Zhang J; Xuan S; Liu Z; Wang Y; Zhao P
Front Cell Dev Biol; 2021; 9():600506. PubMed ID: 33614641
[No Abstract] [Full Text] [Related]
5. Characterization of an endoplasmic reticulum stress-related signature to evaluate immune features and predict prognosis in glioma.
Zhang Q; Guan G; Cheng P; Cheng W; Yang L; Wu A
J Cell Mol Med; 2021 Apr; 25(8):3870-3884. PubMed ID: 33611848
[TBL] [Abstract][Full Text] [Related]
6. Predicting lung adenocarcinoma prognosis with a novel risk scoring based on platelet-related gene expression.
Zhou C; Wang Y; Wang Y; Lei L; Ji MH; Zhou G; Xia H; Yang JJ
Aging (Albany NY); 2021 Feb; 13(6):8706-8719. PubMed ID: 33619234
[TBL] [Abstract][Full Text] [Related]
7. Identification of unanimous immune subtypes for different hormone receptor phenotypes of human breast cancer with potential prognostic significance.
Yu C; Zhou L; Zhang Q
Int Immunopharmacol; 2021 May; 94():107473. PubMed ID: 33611062
[TBL] [Abstract][Full Text] [Related]
8. E3 ubiquitin ligase RNF126 affects bladder cancer progression through regulation of PTEN stability.
Xu H; Ju L; Xiong Y; Yu M; Zhou F; Qian K; Wang G; Xiao Y; Wang X
Cell Death Dis; 2021 Mar; 12(3):239. PubMed ID: 33664240
[TBL] [Abstract][Full Text] [Related]
9. SEOM clinical guidelines for the treatment of advanced prostate cancer (2020).
González Del Alba A; Méndez-Vidal MJ; Vazquez S; Castro E; Climent MA; Gallardo E; Gonzalez-Billalabeitia E; Lorente D; Maroto JP; Arranz JA
Clin Transl Oncol; 2021 May; 23(5):969-979. PubMed ID: 33625671
[TBL] [Abstract][Full Text] [Related]
10. Bladder preservation therapy in combination with atezolizumab and radiation therapy for invasive bladder cancer (BPT-ART) - A study protocol for an open-label, phase II, multicenter study.
Sekino Y; Ishikawa H; Kimura T; Kojima T; Maruo K; Azuma H; Yoshida K; Kageyama Y; Ushijima H; Tsuzuki T; Sakurai H; Nishiyama H
Contemp Clin Trials Commun; 2021 Mar; 21():100724. PubMed ID: 33615035
[TBL] [Abstract][Full Text] [Related]
11. Identification and Validation of an Autophagy-Related lncRNA Signature for Patients With Breast Cancer.
Zhang R; Zhu Q; Yin D; Yang Z; Guo J; Zhang J; Zhou Y; Yu JJ
Front Oncol; 2020; 10():597569. PubMed ID: 33614483
[TBL] [Abstract][Full Text] [Related]
12. Identification of a Metastasis-Associated Gene Signature of Clear Cell Renal Cell Carcinoma.
Gao S; Yan L; Zhang H; Fan X; Jiao X; Shao F
Front Genet; 2020; 11():603455. PubMed ID: 33613617
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of an individual alternative splicing prognostic signature in gastric cancer.
Lou S; Zhang J; Zhai Z; Yin X; Wang Y; Fang T; Xue Y
Aging (Albany NY); 2021 Feb; 13(4):5824-5844. PubMed ID: 33612482
[TBL] [Abstract][Full Text] [Related]
14. CD96 Correlates With Immune Infiltration and Impacts Patient Prognosis: A Pan-Cancer Analysis.
Ye W; Luo C; Liu F; Liu Z; Chen F
Front Oncol; 2021; 11():634617. PubMed ID: 33680972
[TBL] [Abstract][Full Text] [Related]
15. Correlation of immune infiltration with clinical outcomes in breast cancer patients: The 25-gene prognostic signatures model.
Liu Y; Fu W; Chen W; Lin Y; Zhang J; Song C
Cancer Med; 2021 Mar; 10(6):2112-2124. PubMed ID: 33626234
[TBL] [Abstract][Full Text] [Related]
16. Bladder cancer cell-intrinsic PD-L1 signals promote mTOR and autophagy activation that can be inhibited to improve cytotoxic chemotherapy.
Zhang D; Reyes RM; Osta E; Kari S; Gupta HB; Padron AS; Kornepati AVR; Kancharla A; Sun X; Deng Y; Wu B; Vadlamudi R; Li R; Svatek RS; Curiel TJ
Cancer Med; 2021 Mar; 10(6):2137-2152. PubMed ID: 33626233
[TBL] [Abstract][Full Text] [Related]
17. Construction of a robust prognostic model for adult adrenocortical carcinoma: Results from bioinformatics and real-world data.
Tian X; Xu WH; Anwaier A; Wang HK; Wan FN; Cao DL; Luo WJ; Shi GH; Qu YY; Zhang HL; Ye DW
J Cell Mol Med; 2021 Apr; 25(8):3898-3911. PubMed ID: 33626208
[TBL] [Abstract][Full Text] [Related]
18. Determination of hypoxia signature to predict prognosis and the tumor immune microenvironment in melanoma.
Shou Y; Yang L; Yang Y; Zhu X; Li F; Xu J
Mol Omics; 2021 Apr; 17(2):307-316. PubMed ID: 33624645
[TBL] [Abstract][Full Text] [Related]
19. Alpelisib for the treatment of
Leenhardt F; Alexandre M; Jacot W
Expert Opin Pharmacother; 2021 Apr; 22(6):667-675. PubMed ID: 33622114
[No Abstract] [Full Text] [Related]
20. Development and validation of a three-immune-related gene signature prognostic risk model in papillary thyroid carcinoma.
Gan X; Guo M; Chen Z; Li Y; Shen F; Feng J; Cai W; Xu B
J Endocrinol Invest; 2021 Oct; 44(10):2153-2163. PubMed ID: 33620716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
